AAAAAA

   
Results: 1-22 |
Results: 22

Authors: CHANG WH LIN SK LANE HY WEI FC HU WH LAM YWF JANN MW
Citation: Wh. Chang et al., REVERSIBLE METABOLISM OF CLOZAPINE AND CLOZAPINE N-OXIDE IN SCHIZOPHRENIC-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 22(5), 1998, pp. 723-739

Authors: ALFARO CL LAM YWF ERESHEFSKY L MILLER M
Citation: Cl. Alfaro et al., COADMINISTRATION OF ANTIDEPRESSANTS(AD) OR KETOCONAZOLE (K) WITH ORALMIDAZOLAM (M) - PHARMACODYNAMIC (PD) INTERACTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 67-67

Authors: LAM YWF ALFARO CL ERESHEFSKY L MILLER M
Citation: Ywf. Lam et al., EFFECT OF ANTIDEPRESSANTS (AD) AND KETOCONAZOLE (K) ON ORAL MIDAZOLAM(M) PHARMACOKINETICS (PK), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 90-90

Authors: LAM YWF BANERJI S HATFIELD C TALBERT RL
Citation: Ywf. Lam et al., PRINCIPLES OF DRUG ADMINISTRATION IN RENAL-INSUFFICIENCY, Clinical pharmacokinetics, 32(1), 1997, pp. 30-57

Authors: JANN MW CRABTREE BL PITTS WM LAM YWF CARTER JG
Citation: Mw. Jann et al., PLASMA ALPHA-ONE ACID GLYCOPROTEIN AND HALOPERIDOL CONCENTRATIONS IN SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 36(1), 1997, pp. 32-36

Authors: ALFARO C ERESHEFSKY L LAM YWF
Citation: C. Alfaro et al., RELATIONSHIP OF VENLAFAXINE, FLUOXETINE, SERTRALINE, AND PAROXETINE PLASMA-CONCENTRATION WITH CYP 2D6 INHIBITION, Psychopharmacology bulletin, 33(3), 1997, pp. 488-488

Authors: ERESHEFSKY L ALFARO CL LAM YWF
Citation: L. Ereshefsky et al., TREATING DEPRESSION - POTENTIAL-DRUG INTERACTIONS, Psychiatric annals, 27(4), 1997, pp. 244

Authors: LIN SK CHANG WH CHIEN CP LAM YWF JANN MW
Citation: Sk. Lin et al., DISPOSITION OF REMOXIPRIDE IN CHINESE SCHIZOPHRENIC-PATIENTS, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 17-20

Authors: ERESHEFSKY L RIESENMAN C LAM YWF
Citation: L. Ereshefsky et al., SEROTONIN SELECTIVE REUPTAKE INHIBITOR DRUG-INTERACTIONS AND THE CYTOCHROME-P450 SYSTEM, The Journal of clinical psychiatry, 57, 1996, pp. 17-25

Authors: HUANG HF JANN MW WEI FC CHANG TP CHEN JS JUANG DJ LIN SK LAM YWF CHIEN CP CHANG WH
Citation: Hf. Huang et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN BUSPIRONE AND HALOPERIDOLIN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical pharmacology, 36(10), 1996, pp. 963-969

Authors: RIESENMAN C ERESHEFSKY L LAM YWF
Citation: C. Riesenman et al., IN-VIVO RELATIONSHIP OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR PLASMA-CONCENTRATION WITH CYP2D6 INHIBITION, Psychopharmacology bulletin, 32(3), 1996, pp. 503-503

Authors: RIESENMAN CL LAM YWF ERESHEFSKY L
Citation: Cl. Riesenman et al., INTRAINDIVIDUAL VARIABILITY OF THE DEXTROMETHORPHAN DEXTRORPHAN (DM/DP) RATIO IN EXTENSIVE METABOLIZERS/, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 31-31

Authors: CHANG WH JUANG DJ LIN SK HUANG JD LAM YWF JANN MW CHIEN CP
Citation: Wh. Chang et al., DISPOSITION OF HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-LEVELS AFTER SINGLE-DOSE HALOPERIDOL DECANOATE ADMINISTRATION, Human psychopharmacology, 10(1), 1995, pp. 47-51

Authors: LAM YWF FLAHERTY JF YUMENA L SCHOENFELD PY GAMBERTOGLIO JG
Citation: Ywf. Lam et al., ROXITHROMYCIN DISPOSITION IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 157-163

Authors: LAM YWF JANN MW CHANG WH YU HS LIN SK CHEN H DAVIS CM
Citation: Ywf. Lam et al., INTRAETHNIC AND INTERETHNIC VARIABILITY IN REDUCED HALOPERIDOL TO HALOPERIDOL RATIOS, Journal of clinical pharmacology, 35(2), 1995, pp. 128-136

Authors: CASTILLO M LAM YWF DOOLEY MA STAHL E SMITH PC
Citation: M. Castillo et al., DISPOSITION AND COVALENT BINDING OF IBUPROFEN AND ITS ACYL GLUCURONIDE IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 636-644

Authors: LIU JH STAHL E DOOLEY MA LAM YWF SMITH PC
Citation: Jh. Liu et al., DISPOSITION AND COVALENT BINDING OF SALICYLIC-ACID AND ITS ACYL GLUCURONIDE IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 183-183

Authors: JANN MW HUANG HF LIN SK JUANG DJ LAM YWF CHANG WH
Citation: Mw. Jann et al., FORMATION OF REDUCED HALOPERIDOL AFTER INTRAMUSCULAR HALOPERIDOL ADMINISTRATION IN SCHIZOPHRENIC-PATIENTS, Drug investigation, 7(1), 1994, pp. 18-25

Authors: LIN SK CHANG WH CHUNG MC LAM YWF JANN MW
Citation: Sk. Lin et al., DISPOSITION OF CLOZAPINE AND DESMETHYLCLOZAPINE IN SCHIZOPHRENIC-PATIENTS, Journal of clinical pharmacology, 34(4), 1994, pp. 318-324

Authors: JANN MW LAM YWF CHANG WH
Citation: Mw. Jann et al., RAPID FORMATION OF CLOZAPINE IN GUINEA-PIGS AND MAN FOLLOWING CLOZAPINE-N-OXIDE ADMINISTRATION, Archives internationales de pharmacodynamie et de therapie, 328(2), 1994, pp. 243-250

Authors: RICHER M LAM YWF
Citation: M. Richer et Ywf. Lam, HYPOXIA, ARTERIAL PH AND THEOPHYLLINE DISPOSITION, Clinical pharmacokinetics, 25(4), 1993, pp. 283-299

Authors: LAM YWF RODRIGUEZ SY
Citation: Ywf. Lam et Sy. Rodriguez, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF DEXTROMETHORPHAN AND DEXTRORPHAN FOR OXIDATION PHENOTYPING BY FLUORESCENCE AND ULTRAVIOLET DETECTION, Therapeutic drug monitoring, 15(4), 1993, pp. 300-304
Risultati: 1-22 |